Whittier Trust Co. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,745 shares of the healthcare conglomerate's stock after selling 44,938 shares during the period. Whittier Trust Co.'s holdings in UnitedHealth Group were worth $14,270,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. Nabity Jensen Investment Management Inc raised its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock worth $1,446,000 after purchasing an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate's stock worth $160,000 after purchasing an additional 25 shares in the last quarter. HHM Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate's stock worth $1,544,000 after purchasing an additional 26 shares in the last quarter. Brogan Financial Inc. raised its holdings in shares of UnitedHealth Group by 3.4% in the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate's stock worth $429,000 after purchasing an additional 27 shares in the last quarter. Finally, West Wealth Group LLC raised its holdings in shares of UnitedHealth Group by 3.2% in the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate's stock worth $462,000 after purchasing an additional 27 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
Shares of UNH opened at $364.31 on Tuesday. The company's 50 day moving average price is $331.62 and its 200 day moving average price is $341.12. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a market capitalization of $329.95 billion, a PE ratio of 15.78, a PEG ratio of 2.31 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on UNH. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Barclays boosted their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an "overweight" rating in a report on Thursday, October 9th. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a report on Thursday, October 9th. Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a report on Tuesday, October 7th. Finally, Truist Financial boosted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company's stock. According to MarketBeat, UnitedHealth Group has an average rating of "Hold" and a consensus price target of $385.13.
Get Our Latest Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.